ProShares Ultra NASDAQ Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIB and other ETFs, options, and stocks.

About BIB

BIB provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. The listed name for BIB is ProShares Trust ProShares Ultra Nasdaq Biotechnology. 

Index-Tracked
NASDAQ Composite TR USD
Index-TrackedNASDAQ Composite TR USD
Category
Trading--Leveraged Equity
CategoryTrading--Leveraged Equity
Number of holdings
256
Number of holdings256
Inception Date
Apr 6, 2010
Inception DateApr 6, 2010

BIB Key Statistics

AUM
86.02M
AUM86.02M
Price-Earnings ratio
Price-Earnings ratio
30-Day yield
30-Day yield
Average volume
20.70K
Average volume20.70K
High today
$82.44
High today$82.44
Low today
$80.82
Low today$80.82
Open price
$82.33
Open price$82.33
Volume
11.07K
Volume11.07K
52 Week high
$84.06
52 Week high$84.06
52 Week low
$33.78
52 Week low$33.78
Expense ratio
1.19
Expense ratio1.19

Stock Snapshot

As of today, ProShares Ultra NASDAQ Biotech(BIB) shares are valued at $81.16. The company's market cap stands at 86M.

During the trading session on 2025-12-06, ProShares Ultra NASDAQ Biotech(BIB) shares reached a daily high of $82.44 and a low of $80.82. At a current price of $81.16, the stock is +0.4% higher than the low and still -1.5% under the high.

Trading volume for ProShares Ultra NASDAQ Biotech(BIB) stock has reached 11.07K, versus its average volume of 20.7K.

Over the past 52 weeks, ProShares Ultra NASDAQ Biotech(BIB) stock has traded between a high of $84.06 and a low of $33.78.

Over the past 52 weeks, ProShares Ultra NASDAQ Biotech(BIB) stock has traded between a high of $84.06 and a low of $33.78.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.